Vol 47, No 4, October 2010
Chronic Myelogenous Leukemia in the Imatinib Era
Jorge Cortes-Franco, Guest Editor
Vol 47, No 3, July 2010
New Thrombopoietic Agents
James Bussel and David Kuter, Guest Editors
Vol 47, Supplement 1, April 2010
Peripheral T-Cell Lymphomas: Challenges in Diganosis and Treatment
Francine M. Foss, Guest Editor
Vol 47, No 2, April 2010
Rituximab
Adrian Wiestner, Guest Editor
Vol 47, No 1, January 2010
Umbilical Cord Transplantation
John E. Wagner MD, Guest Editor
Vol 46, No 4, October 2009
Iron Deficiency and Metabolism
Lawrence T. Goodnough, Guest Editor
Vol 46, No 3, July 2009
Infections in Patients With Hematologic Malignancies, Transplantation, and Aplastic Anemia
Thomas J. Walsh MD, Guest Editor
Vol 46, No 2, April 2009
New Therapeutic Strategies for Multiple Myeloma
Meletios A. Dimopoulos MD, Michel Attal MD, Guest Editors
Volume 46, Supplement 3, January 2009
New Directions in the Treatment of Patients With Chronic Myeloid Leukemia
Michele Baccarani MD, Guest Editor
Vol 46, Supplement 2 January 2009
The Changing Landscape of Secondary ITP
James B. Bussel, Guest Editor
Vol 46, Supplement 1 January 2009
The Management of Paroxysmal Nocturnal Hemoglobinuria: Recent Advances in Diagnosis and Treatment and New Hope for Patients
Peter Hillmen MD, Guest Editor
Vol 46, No 1 January 2009
Acute Lymphoblastic Leukemia
Ching-Hon Pui MD, Guest Editor
Vol 45, No 4, October 2008
Anemia in the Elderly
Elizabeth A. Price, Stanley L. Schrier, Guest Editors
Vol 43, No 3S, Supplement 2 July 2008
Evolution of Targeted and Multifunctional Agents for Leukemias and Lymphomas
Martin S. Tallman, Guest Editor
-
Vol 43, No 3, July 2008
Interpretation of Quantitative Research
John P.A. Ioannidis, Guest Editor
Vol 45 No 2S, Supplement 1, April 2008
9th Novo Nordisk Symposium on Haemostasis Management
E. Carlos Rodriquez-Merchan, Guest Editor
Vol 45, No 2, April 2008
Monoclonal Antibodies for the Treatment of Hematologic Malignancies
J.W. Friedberg, Guest Editor
Vol 45, No 1, January 2008
Myelodysplastic Syndromes
Elaine Sloand, Guest Editor
Vol 44, No S5, October 2007
Immune-Mediated Thrombocytopenias: Focus on Chronic Immune Thrombocytopenic Purpura
Robert McMillan, Guest Editor
Vol 44, No 4, October 2007
Autologous Stem Cell Transplantation
Theo de Witte, Guest Editor
Vol 44, No 3, July 2007
Hematopoietic Growth Factors
Arnold Ganser, Guest Editor
Vol 44, No 2, April 2007
Inherited Thrombophilias
Michael Greaves, Guest Editor
Vol 44, No 1, January 2007
Transfusion Medicine in the Early 21st Century
Harvey G. Klein, Guest Editor
Vol 43, No 4, October 2006
Treatment of Diffuse Large B-Cell Lymphomas
Richard I. Fisher, Guest Editor
Vol 43, No 3, July 2006
Constitutional Marrow Failure
Grover C. Bagby, Guest Editor
Vol 43, No 2, April 2006
Acute Leukemia in the Elderly
Elihu H. Estey, Guest Editor
Vol 43, No 1, January 2006
Graft-Versus-Host Disease
James L.M. Ferrara and John E. Levine, Guest Editors
Vol 42, No 4, October 2005
Chronic Myeloproliferative Disorders
Radek Skoda and Josef T. Prchal, Guest Editors
Vol 42, No 3, July 2005
Transplant Immunobiology
Effie W. Petersdorf, Guest Editor
Vol 42, No 2, April 2005
Immune Hemolytic Anemia
George Garratty, Guest Editor
Vol 42, No 1, January 2005
von Willebrand Factor in Hemostasis and Thrombosis
Pier M. Mannucci, Guest Editor
Vol 41, No 4, October 2004
Gene Therapy in Hematology
Cynthia E. Dunbar, Guest Editor
Vol 41, No 3, July 2004
Chronic Lymphocytic Leukemia
Kanti R. Rai and Jacques Louis Binet, Guest Editors
Vol 41, No 2, April 2004
Erythrocyte Membrane Proteins and Their Diseases
Narla Mohandas, Guest Editor
Vol 41, No 1, January 2004
Thrombotic Thrombocytopenic Purpura: Advances in Pathophysiology, Diagnosis, and Treatment
Bernhard Lammle and James N. George, Guest Editors
Vol 40, No 4, October 2003
Genomics in Hematology
Louis M. Staudt, Guest Editor
Vol 40, No 3, July 2003
Hematologic Malignancies of Cytotoxic Cells
Thomas P. Loughran Jr, Guest Editor
Vol 40, No 2, April 2003
Herpesvirus in Hematology
Giovanna Tosato, Guest Editor
Vol 40, No 1, January 2003
Management of Chronic Myeloid Leukemia
John M. Goldman, Guest Editor
|
